Targeting inflammatory mediators in epilepsy: a systematic review of its molecular basis and clinical applications

G Costagliola, G Depietri, A Michev, A Riva… - Frontiers in …, 2022 - frontiersin.org
Introduction Recent studies prompted the identification of neuroinflammation as a potential
target for the treatment of epilepsy, particularly drug-resistant epilepsy, and refractory status …

Second‐line immunotherapy in new onset refractory status epilepticus

A Hanin, E Muscal, LJ Hirsch - Epilepsia, 2024 - Wiley Online Library
Several pieces of evidence suggest immune dysregulation could trigger the onset and
modulate sequelae of new onset refractory status epilepticus (NORSE), including its subtype …

Systemic inflammation as a biomarker of seizure propensity and a target for treatment to reduce seizure propensity

C Stredny, A Rotenberg, A Leviton… - Epilepsia …, 2023 - Wiley Online Library
People with diabetes can wear a device that measures blood glucose and delivers just the
amount of insulin needed to return the glucose level to within bounds. Currently, people with …

New‐onset refractory status epilepticus (NORSE) secondary to Bartonella henselae infection in a pediatric patient

S Sharayah, MM Galardi, S Mar - Annals of Child Neurology …, 2023 - search.proquest.com
Introduction New-onset refractory status epilepticus (NORSE) is a rare and devastating
clinical entity, often without a clearly identified etiology despite extensive testing or known …

[PDF][PDF] Naujai pasireiškusi refrakterinė epilepsinė būklė (NORSE): klinikinis pasireiškimas, diagnostika ir gydymas

L Strelkauskas, S Cyrolytė, V Mačiulytė - … Sveikatos mokslai, 2022, t. 32, Nr …, 2022 - sm-hs.eu
Tyrimo tikslas–išanalizuoti ir aptarti įrodymais pagrįstą informaciją apie naujai
pasireiškusios refrakterinės epilepsinės būklės etiologiją, klinikinę išraišką, diagnostiką ir …